Mitotic catastrophe–related six-gene signature predicts prognosis, tumor immune landscape, and therapeutic response in lung adenocarcinoma
Abstract Background Lung adenocarcinoma (LUAD) exhibits significant molecular and immune heterogeneity, limiting the prognostic and therapeutic value of single biomarkers. Mitotic catastrophe (MC) is a key biological axis, but externally validated MC-related gene (MCRG) signatures integrating immune...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2026-05-01
|
| Cyfres: | BMC Medical Genomics |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s12920-026-02380-z |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|